Alinastine

Drug Profile

Alinastine

Alternative Names: F 91506; F 91506 RR; Lamiakast

Latest Information Update: 14 Sep 2001

Price : $50

At a glance

  • Originator FAES Farma
  • Class Antiallergics; Antiasthmatics; Benzimidazoles; Piperidines
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Allergic conjunctivitis; Asthma; Skin disorders

Most Recent Events

  • 14 Sep 2001 Discontinued-Preclinical for Allergic conjunctivitis in Spain (Ophthalmic)
  • 14 Sep 2001 Discontinued-Preclinical for Asthma in Spain (PO)
  • 14 Sep 2001 Discontinued-Preclinical for Skin disorders in Spain (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top